| Lificiguat | IC50 | 1500.0 [1], 2000.0 [2], 9210.0 [3], 13800.0 [4], 30000.0 [5] |
| 7,18-Bis[3-(dimethylamino)propyl]-7,18-diazaheptacyclo[14.6.2.22,5.03,12.04,9.013,23.020,24]hexacosa-1(23),2,4,9,11,13,15,20(24),21,25-decaene-6,8,17,19-tetrone | IC50 | 3000.0 [1] |
| Chaetocin | IC50 | 40.0 [1], 100.0 [2], 12500.0 [3] |
| Moracin P | IC50 | 0.65 [1], 10600.0 [2], 10700.0 [3] |
| CID 16124726 | IC50 | 2440.0 [1], 4400.0 [2], 21000.0 [3] |
| 3-[2-(4-Adamant-1-yl-phenoxy)-acetylamino]-benzoic acid methyl ester | IC50 | 700.0 [1], 2600.0 [2], 5030.0 [3] |
| 2-[2-(4-Adamantan-1-yl-phenoxy)-acetylamino]-N-(3-imidazol-1-yl-propyl)-isonicotinamide | IC50 | 900.0 [1], 11000.0 [2], 11200.0 [3] |
| 2-[2-(4-Adamantan-1-yl-phenoxy)-acetylamino]-isonicotinamide | IC50 | 600.0 [1], 1800.0 [2], 3100.0 [3] |
| 5-[2-(4-Adamantan-1-yl-phenoxy)-acetylamino]-N-furan-2-ylmethyl-nicotinamide | IC50 | 4100.0 [1], 30000.0 [2] |
| 2-[2-(4-Adamantan-1-yl-phenoxy)-acetylamino]-isonicotinic acid methyl ester | IC50 | 1030.0 [1], 1200.0 [2], 2000.0 [3] |
| 5-[2-(4-Adamantan-1-yl-phenoxy)acetylamino]-nicotinic acid methyl ester | IC50 | 5000.0 [1], 5900.0 [2], 30000.0 [3] |
| 2-[2-(4-Adamantan-1-yl-phenoxy)-acetylamino]-isonicotinic acid | IC50 | 800.0 [1], 1000.0 [2], 2000.0 [3] |
| 2-[2-(4-Adamantan-1-yl-phenoxy)-acetylamino]-N-furan-2-ylmethyl-isonicotinamide | IC50 | 30000.0 [1] |
| 2-[2-(4-Adamantan-1-yl-phenoxy)-acetylamino]-N-(2-pyridin-4-yl-ethyl)-isonicotinamide | IC50 | 3400.0 [1], 5200.0 [2] |
| 2-[2-(4-Adamantan-1-yl-phenoxy)-acetylamino]-N-(4-chloro-phenyl)-isonicotinamide | IC50 | 2500.0 [1], 18600.0 [2], 30000.0 [3] |
| 5-[2-(4-Adamantan-1-yl-phenoxy)-acetylamino]-nicotinic acid | IC50 | 30000.0 [1] |
| 5-[2-(4-Adamantan-1-yl-phenoxy)-acetylamino]-N-(2-pyridin-4-yl-ethyl)-nicotinamide | IC50 | 1300.0 [1], 30000.0 [2] |
| 5-[2-(4-Adamantan-1-yl-phenoxy)-acetylamino]-N-(3-imidazol-1-yl-propyl)-nicotinamide | IC50 | 1900.0 [1], 10000.0 [2] |
| 5-[2-(4-Adamantan-1-yl-phenoxy)-acetylamino]-nicotinamide | IC50 | 900.0 [1], 10000.0 [2], 11900.0 [3] |
| Topotecan | IC50 | 60.0 [1], 3000.0 [2] |
| Alvespimycin | IC50 | 57.0 [1], 57.2 [2] |
| 5-[(6R)-6-Hydroxy-7,7-dimethyl-5,6-dihydrofuro[3,2-g]chromen-2-yl]benzene-1,3-diol | IC50 | 0.65 [1], 10.7 [2] |
| Moracin O | IC50 | 0.14 [1], 6.76 [2] |
| 3-[2-(4-Adamantan-1-yl-phenoxy)-acetylamino]-benzoic acid | IC50 | 350.0 [1], 400.0 [2] |
| (E)-3-[3-(4-Adamantan-1-yl-phenoxy)-acryloylamino]-benzoic acid methyl ester | IC50 | 740.0 [1] |
| 2-Chloro-N-[6-[4-(chloromethyl)-6-oxo-1H-pyrimidin-2-yl]pyridin-3-yl]acetamide | IC50 | 1500.0 [1], 5500.0 [2] |
| 2-Chloro-N-[6-[6-oxo-4-(trifluoromethyl)-1H-pyrimidin-2-yl]pyridin-3-yl]acetamide | IC50 | 800.0 [1], 8000.0 [2] |
| 2-(5-Aminopyridin-2-yl)-6-(chloromethyl)pyrimidin-4-ol | IC50 | 6000.0 [1], 22000.0 [2] |
| 2-Chloro-N-[6-(5-ethyl-4-methyl-6-oxo-1H-pyrimidin-2-yl)pyridin-3-yl]acetamide | IC50 | 1500.0 [1], 5500.0 [2] |
| N-[6-(5-Benzyl-4-methyl-6-oxo-1H-pyrimidin-2-yl)pyridin-3-yl]-2-chloroacetamide | IC50 | 4000.0 [1], 10000.0 [2] |
| 2-Chloro-N-[6-(5-fluoro-4-methyl-6-oxo-1H-pyrimidin-2-yl)pyridin-3-yl]acetamide | IC50 | 2000.0 [1], 6000.0 [2] |
| 2-Chloro-N-[6-(5-ethyl-4-methyl-6-prop-2-enoxypyrimidin-2-yl)pyridin-3-yl]acetamide | IC50 | 1800.0 [1], 22000.0 [2] |
| 2-Chloro-N-[6-(5-chloro-4-methyl-6-prop-2-enoxypyrimidin-2-yl)pyridin-3-yl]acetamide | IC50 | 1500.0 [1], 8000.0 [2] |
| 2-Chloro-N-[6-[4-methoxy-6-(trifluoromethyl)pyrimidin-2-yl]pyridin-3-yl]acetamide | IC50 | 3500.0 [1], 15000.0 [2] |
| 2-Chloro-N-[6-[4-prop-2-enoxy-6-(trifluoromethyl)pyrimidin-2-yl]pyridin-3-yl]acetamide | IC50 | 2000.0 [1], 30000.0 [2] |
| 2-Chloro-N-[6-[4-chloro-6-(trifluoromethyl)pyrimidin-2-yl]pyridin-3-yl]acetamide | IC50 | 1400.0 [1], 10000.0 [2] |
| (1S,3S,11R,14R)-14-(Hydroxymethyl)-3-[3-[[(1S,4R)-4-(hydroxymethyl)-5,7-dimethyl-6,8-dioxo-2,3-dithia-5,7-diazabicyclo[2.2.2]octan-1-yl]methyl]indol-1-yl]-18-methyl-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.01,12.03,11.04,9]octadeca-4,6,8-triene-13,17-dione | IC50 | 1900.0 [1] |
| Moracin M | IC50 | 50000.0 [1] |
| Sanggenon C | IC50 | 1260.0 [1] |
| Vomifoliol | IC50 | 15800.0 [1] |
| Mulberrofuran G | IC50 | 2600.0 [1] |
| 2-(3,4-Dimethoxyphenyl)-1-(5-methoxy-2,2-dimethyl-2h-chromen-6-yl)ethanone | IC50 | 2150.0 [1] |
| Makaluvamine F | IC50 | 8300.0 [1] |
| 3-Dihydrodiscorhabdin C | IC50 | 35200.0 [1] |
| 3-(2-Ethoxyphenyl)-2-{[4-(2-furoyl)-1-piperazinyl]methyl}-4(3H)-quinazolinone | IC50 | 430.0 [1] |
| Sanggenon O | IC50 | 1030.0 [1] |
| Mulberrofuran W | IC50 | 3620.0 [1] |
| (E)-1-[3-[(1S,5S,6R)-6-[3,5-Dihydroxy-4-(3-methylbut-2-enyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxyphenyl]-3-(2,4-dihydroxyphenyl)prop-2-en-1-one | IC50 | 4100.0 [1] |
| Mulberrofuran D | IC50 | 4050.0 [1] |
| (2,4-Dihydroindeno[1,2-c]pyrazol-3-yl)phenylamine | IC50 | 30000.0 [1] |
| (6-Methoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamine | IC50 | 30000.0 [1] |
| (1S,14S)-19-Bromo-11-hydroxy-15-thia-4,9,13-triazahexacyclo[12.6.1.13,7.01,16.02,12.010,22]docosa-2,7(22),8,10,12,16,19-heptaen-18-one | IC50 | 3700.0 [1] |
| (E)-1-[3-[(1S,5S,6R)-6-[3,5-Dihydroxy-4-(3-methylbut-2-enyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | IC50 | 3170.0 [1] |
| (E)-1-[3-[(1S,5S,6R)-6-[3,5-Dihydroxy-4-(3-methylbut-2-enyl)benzoyl]-5-(4-hydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | IC50 | 8320.0 [1] |
| Albafuran A | IC50 | 3510.0 [1] |
| 2-(3,4-Dimethoxyphenyl)-1-(5-methoxy-2,2-dimethylchromen-6-yl)propan-1-one | IC50 | 1360.0 [1] |
| N-(3-Methoxyphenyl)-1,4-dihydroindeno[1,2-c]pyrazol-3-amine | IC50 | 6100.0 [1] |
| (6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)-phenyl amine | IC50 | 30000.0 [1] |
| (5-Methoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamine | IC50 | 30000.0 [1] |
| (7-Methoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamine | IC50 | 30000.0 [1] |
| Ethyl 5-[(4-bromophenyl)sulfonylamino]-3-methyl-1-benzofuran-2-carboxylate | IC50 | 29900.0 [1] |
| Ethyl 5-[(4-chlorophenyl)sulfonylamino]-3-methyl-1-benzofuran-2-carboxylate | IC50 | 50000.0 [1] |
| Ethyl 3-methyl-5-[[4-(trifluoromethyl)phenyl]sulfonylamino]-1-benzofuran-2-carboxylate | IC50 | 41700.0 [1] |
| 3-[2-(4-Adamantan-1-yl-phenoxy)-acetylamino]-4-hydroxy-benzoic acid | IC50 | 3100.0 [1] |
| Mulberrofuran H | IC50 | 140.0 [1] |
| 1-(4-Aminophenyl)-3-[3-(1,3-benzodioxol-5-yl)-4-oxo-1H-indeno[1,2-c]pyrazol-5-yl]urea | IC50 | 214.0 [1] |
| Methyl 3-[({4-[(phenylcarbamoyl)amino]phenyl}amino)methyl]benzoate | IC50 | 7210.0 [1] |
| (E)-1-[3-[(1R,4R,6R)-6-[2,4-Dihydroxy-3-(3-methylbut-2-enyl)benzoyl]-4-(4-hydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxyphenyl]-3-(2,4-dihydroxyphenyl)prop-2-en-1-one | IC50 | 3800.0 [1] |
| PX-478 free base | IC50 | 20200.0 [1] |
| 4-Chloro-1-[cyclohexyl-(5-methoxy-2,2-dimethylchromen-6-yl)methyl]benzimidazole | IC50 | 7500.0 [1] |
| 3-(2-Ethoxyphenyl)-2-(piperazin-1-ylmethyl)quinazolin-4-one | IC50 | 90.0 [1] |
| Prop-2-ynyl 4-hydroxy-3-[(2-phenoxyacetyl)amino]benzoate | IC50 | 30000.0 [1] |
| 2-[4-(1-Adamantyl)phenoxy]-N-[3-(4-prop-2-ynoxybenzoyl)phenyl]acetamide | IC50 | 30000.0 [1] |
| (E)-3-[4-(1-Adamantyl)phenoxy]-N-[3-(4-prop-2-ynoxybenzoyl)phenyl]prop-2-enamide | IC50 | 30000.0 [1] |
| [4-[3-(Trifluoromethyl)diazirin-3-yl]phenyl]methyl 3-[4-[2-(2-hydroxy-5-prop-2-ynoxycarbonylanilino)-2-oxoethoxy]phenyl]adamantane-1-carboxylate | IC50 | 11400.0 [1] |
| [4-[3-(Trifluoromethyl)diazirin-3-yl]phenyl]methyl 3-(4-prop-2-ynoxyphenyl)adamantane-1-carboxylate | IC50 | 30000.0 [1] |
| Prop-2-ynyl 4-hydroxy-3-[[2-[2-[3-(trifluoromethyl)diazirin-3-yl]phenoxy]acetyl]amino]benzoate | IC50 | 30000.0 [1] |
| 2-(3,4-Dimethoxyphenyl)-1-(5-methoxy-2,2-dimethylchromen-6-yl)-3-phenylpropan-1-one | IC50 | 12030.0 [1] |
| 2-(2-Hydroxyphenyl)-1-(5-methoxy-2,2-dimethylchromen-6-yl)ethanone | IC50 | 940.0 [1] |
| 2-(3,4-Dimethoxyphenyl)-1-(5-methoxy-2,2-dimethylchromen-6-yl)pent-4-en-1-one | IC50 | 8450.0 [1] |
| 2-(3-Fluorophenyl)-1-(5-methoxy-2,2-dimethylchromen-6-yl)ethanone | IC50 | 360.0 [1] |
| 2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-1-(5-methoxy-2,2-dimethylchromen-6-yl)ethanone | IC50 | 1330.0 [1] |
| 2-(3,4-Dimethoxyphenyl)-2-fluoro-1-(5-methoxy-2,2-dimethylchromen-6-yl)ethanone | IC50 | 6350.0 [1] |
| 2-(2-Fluorophenyl)-1-(5-methoxy-2,2-dimethylchromen-6-yl)ethanone | IC50 | 100.0 [1] |
| 1-(5-Methoxy-2,2-dimethylchromen-6-yl)-2-(3-methoxyphenyl)ethanone | IC50 | 820.0 [1] |
| 1-(5-Methoxy-2,2-dimethylchromen-6-yl)-2-phenylethanone | IC50 | 880.0 [1] |
| 2-(3-Hydroxyphenyl)-1-(5-methoxy-2,2-dimethylchromen-6-yl)ethanone | IC50 | 1440.0 [1] |
| 2-(4-Hydroxyphenyl)-1-(5-methoxy-2,2-dimethylchromen-6-yl)ethanone | IC50 | 790.0 [1] |
| 1-(5-Methoxy-2,2-dimethylchromen-6-yl)-2-(2-methoxyphenyl)ethanone | IC50 | 3210.0 [1] |
| 2-(4-Fluorophenyl)-1-(5-methoxy-2,2-dimethylchromen-6-yl)ethanone | IC50 | 1020.0 [1] |
| 2-(3,4-Difluorophenyl)-1-(5-methoxy-2,2-dimethylchromen-6-yl)ethanone | IC50 | 1270.0 [1] |
| 1-(5-Methoxy-2,2-dimethylchromen-6-yl)-2-(4-methoxyphenyl)ethanone | IC50 | 6210.0 [1] |
| 2-(3,4-Dichlorophenyl)-1-(5-methoxy-2,2-dimethylchromen-6-yl)ethanone | IC50 | 2880.0 [1] |
| Ethyl 5-[(3,4-dimethoxyphenyl)sulfonylamino]-3-methyl-1-benzofuran-2-carboxylate | IC50 | 12500.0 [1] |
| Methyl 3-[4-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]butanoylamino]benzoate | IC50 | 1400.0 [1] |
| (1R,14S,19S,20R)-11,20-Dihydroxy-15-thia-9,13-diaza-4-azoniaheptacyclo[12.6.1.13,7.01,16.02,12.04,19.010,22]docosa-2(12),3,7(22),8,10,16-hexaen-18-one | IC50 | 730.0 [1] |
| 6-(4-Chlorophenyl)-2-[5-methyl-1-[(4-methylphenyl)methyl]pyrazol-3-yl]-1H-benzimidazole | IC50 | 3.0 [1] |
| 2-(5-Aminopyridin-2-yl)-5-chloro-6-methylpyrimidin-4-ol | IC50 | 30000.0 [1] |
| 2-(5-Aminopyridin-2-yl)-6-trifluoromethylpyrimidin-4-ol | IC50 | 30000.0 [1] |
| 2-(5-Aminopyridin-2-yl)-5,6-dimethylpyrimidin-4-ol | IC50 | 30000.0 [1] |